Pseudoexfoliation and Chronic Kidney Disease
The Relationship Between Pseudoexfoliation and Chronic Kidney Disease
The Relationship Between Pseudoexfoliation and Chronic Kidney Disease
Sponsor study identifier
observational
358
1 country
1
Study Start
October 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 2012
Actual (reported)Background: Pseudoexfoliation (PEX) is characterised by the deposition of fibrillar material in an eye structures and many other parts of the body including kidneys and blood vessels. As both PEX and chronic kidney disease (CKD) are associated with oxidative stress and endothelial dysfunction we studied if the risk of PEX was increased in patients with CKD. Methods: Patients over age 40 with the diagnosis of CKD were included in the study. Chronic kidney disease was diagnosed as decreased glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m². Study groups were arranged as group 1 consisting of HD receiving patients, group 2 consisting of stage 1-4 CKD patients and group 3 consisting of patients with normal kidney functions (control group). Demographic properties and the rate of PEX were evaluated and compaired between the groups.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2012
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2011
Date type not reportedThis date has not been verified as actual or estimated.
April 2012
Actual (reported)September 20, 2012
Actual (reported)September 26, 2012
Actual (reported)Prevalance of pseudoexfoliation in patients with chronic kidney disease
7 months
Patients with stage 5 chronic kidney disease undergoing haemodialysis
Stage 1-4 Chronic kidney disease patients
Patients with normal renal functions
Patients from nephrology clinic
Corum State Hospital
Çorum, 19000, Turkey (Türkiye)
Leyla Niyaz, M.D.
Specialist in Ophthalmology
358 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2012
First Posted
September 26, 2012
Study Start
October 2011
Date type not reportedThis date has not been verified as actual or estimated.
Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD)
Contact the study team to confirm eligibility.
Study Completion
April 2012
Actual (reported)Last Updated
September 26, 2012
Record last verified: 2012-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: